Total Debt
$80.5M
Net Debt
-$570.5M
Kymera Therapeutics, Inc. currently has $80.5M in total debt. Net debt is -$570.5M after cash offsets. This 'Net Cash' position indicates exceptional financial strength.
Financial Fundamentals
KYMR • Quarterly Data • 5Y View
| Date | Total Debt ($B) | Cash & Inv. ($B) | Net Debt ($B) | Total Assets | Debt/Assets |
|---|---|---|---|---|---|
| 2026-03-31 | 0.08 | 0.65 | -0.57Net Cash | 1.67 | 4.8% |
| 2025-12-31 | 0.08 | 0.85 | -0.77Net Cash | 1.74 | 4.7% |
| 2025-09-30 | 0.08 | 0.51 | -0.42Net Cash | 1.10 | 7.6% |
| 2025-06-30 | 0.09 | 0.67 | -0.58Net Cash | 1.13 | 7.6% |
| 2025-03-31 | 0.09 | 0.46 | -0.38Net Cash | 0.92 | 9.4% |
| 2024-12-31 | 0.09 | 0.49 | -0.40Net Cash | 0.98 | 9.0% |
| 2024-09-30 | 0.09 | 0.55 | -0.46Net Cash | 1.03 | 8.5% |
| 2024-06-30 | 0.09 | 0.51 | -0.42Net Cash | 0.83 | 10.7% |
| 2024-03-31 | 0.09 | 0.52 | -0.43Net Cash | 0.87 | 10.0% |
| 2023-12-31 | 0.08 | 0.37 | -0.29Net Cash | 0.58 | 14.7% |
| 2023-09-30 | 0.08 | 0.36 | -0.28Net Cash | 0.55 | 14.6% |
| 2023-06-30 | 0.08 | 0.37 | -0.29Net Cash | 0.58 | 12.9% |
| 2023-03-31 | 0.07 | 0.40 | -0.33Net Cash | 0.61 | 11.2% |
| 2022-12-31 | 0.02 | 0.41 | -0.39Net Cash | 0.60 | 2.9% |
| 2022-09-30 | 0.02 | 0.48 | -0.47Net Cash | 0.64 | 2.6% |
| 2022-06-30 | 0.02 | 0.39 | -0.38Net Cash | 0.52 | 3.3% |
| 2022-03-31 | 0.02 | 0.42 | -0.40Net Cash | 0.56 | 3.1% |
| 2021-12-31 | 0.02 | 0.44 | -0.42Net Cash | 0.61 | 3.0% |
| 2021-09-30 | 0.02 | 0.54 | -0.52Net Cash | 0.64 | 2.9% |
| 2021-06-30 | 0.02 | 0.36 | -0.34Net Cash | 0.43 | 4.2% |
| 2021-03-31 | 0.02 | 0.33 | -0.32Net Cash | 0.46 | 3.8% |
| 2020-12-31 | 0.02 | 0.30 | -0.28Net Cash | 0.49 | 3.7% |
| 2020-09-30 | 0.02 | 0.29 | -0.28Net Cash | 0.51 | 3.5% |
| 2020-06-30 | 0.02 | 0.16 | -0.14Net Cash | 0.18 | 10.5% |
| 2019-12-31 | 0.02 | 0.09 | -0.07Net Cash | 0.12 | 18.2% |